Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population.
Suzuki K, Ohtake N, Nakata S, Takei T, Matsui H, Ono Y, Nakazato H, Hasumi M, Koike H, Ito K, Fukabori Y, Kurokawa K, Yamanaka H.
Suzuki K, et al. Among authors: ito k.
Anticancer Res. 2002 Nov-Dec;22(6B):3507-11.
Anticancer Res. 2002.
PMID: 12552947